2seventy bio Inc (TSVT)
4.93
+0.33
(+7.17%)
USD |
NASDAQ |
May 02, 16:00
4.93
0.00 (0.00%)
After-Hours: 18:02
2seventy bio Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
Date | Value |
---|---|
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | |
December 31, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2020
--
Maximum
Dec 2020
--
Average
--
Median
Dec 2020
Debt to Equity Ratio Benchmarks
Bristol-Myers Squibb Co | 3.376 |
Johnson & Johnson | 0.4803 |
Regeneron Pharmaceuticals Inc | 0.0763 |
Macrogenics Inc | 0.00 |
Akebia Therapeutics Inc | -1.134 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 565.43M |
Total Liabilities (Quarterly) | 310.13M |
Shareholders Equity (Quarterly) | 255.30M |
Current Ratio | 3.977 |